Khiron Life Sciences Corp.
Rank 57
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.7656
USD
-1.90%
Market cap
$87,220,324
Total volume
$276,998
Shares outstanding
113,927,120
Rank 57
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$201,503
|
72.75% |
$0.7656
|
| KHRNF |
Total volume
$75,495
|
27.25% |
Stock price
$0.7700
|
Chart